- Home
- LEGN vs ACT Comparison
LEGN vs ACT Comparison
Compare LEGN & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- ACT
- Stock Information
- Founded
- LEGN 2014
- ACT 1981
- Country
- LEGN United States
- ACT United States
- Employees
- LEGN N/A
- ACT N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- ACT Specialty Insurers
- Sector
- LEGN Health Care
- ACT Finance
- Exchange
- LEGN Nasdaq
- ACT Nasdaq
- Market Cap
- LEGN 5.4B
- ACT 5.3B
- IPO Year
- LEGN 2020
- ACT 2021
- Fundamental
- Price
- LEGN $35.56
- ACT $38.74
- Analyst Decision
- LEGN Strong Buy
- ACT Hold
- Analyst Count
- LEGN 10
- ACT 3
- Target Price
- LEGN $73.67
- ACT $39.67
- AVG Volume (30 Days)
- LEGN 1.1M
- ACT 284.0K
- Earning Date
- LEGN 08-11-2025
- ACT 07-30-2025
- Dividend Yield
- LEGN N/A
- ACT 2.17%
- EPS Growth
- LEGN N/A
- ACT 6.06
- EPS
- LEGN N/A
- ACT 4.41
- Revenue
- LEGN $796,838,000.00
- ACT $1,223,030,000.00
- Revenue This Year
- LEGN $66.76
- ACT $4.43
- Revenue Next Year
- LEGN $52.58
- ACT $4.30
- P/E Ratio
- LEGN N/A
- ACT $8.76
- Revenue Growth
- LEGN 74.75
- ACT 3.15
- 52 Week Low
- LEGN $27.34
- ACT $30.79
- 52 Week High
- LEGN $59.62
- ACT $38.85
- Technical
- Relative Strength Index (RSI)
- LEGN 35.54
- ACT 67.69
- Support Level
- LEGN $35.10
- ACT $37.52
- Resistance Level
- LEGN $38.35
- ACT $38.07
- Average True Range (ATR)
- LEGN 1.31
- ACT 0.66
- MACD
- LEGN -0.37
- ACT 0.17
- Stochastic Oscillator
- LEGN 11.33
- ACT 96.41
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.